Effectiveness of Carboplatin and Paclitaxel as First- and Second-Line Treatment in 61 Patients with Metastatic Melanoma - an article in the open source journal PlosOne. German study.

Synergistic anti-tumor activity of isochaihulactone and paclitaxel on human lung cancer cells.

Paclitaxel gelatin nanoparticles for intravesical bladder cancer therapy.

Protection of neuronal calcium sensor 1 protein in cells treated with paclitaxel.

Safety and Efficacy of nab-Paclitaxel in the Treatment of Patients with Breast Cancer

Molecular mechanism of the schedule-dependent synergistic interaction in EGFR-mutant non-small cell lung cancer cell lines treated with paclitaxel and gefitinib - Chinese study

Clinical trials and progress with paclitaxel in ovarian cancer

Neoadjuvant paclitaxel and cisplatin in uterine cervical cancer: long-term results

Taxol, a microtubule stabilizer, prevents atrial fibrillation in in vitro atrial fibrillation models using rabbit hearts.

Chemosensitization of human leukemia K562 cells to taxol by a Vanadium-salen complex.

Pemetrexed combined with paclitaxel: a dose-finding study evaluating three schedules in solid tumors.

Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma.

Safety and pharmacokinetics of paclitaxel and the oral mTOR inhibitor everolimus in advanced solid tumours - British Journal of Cancer

Prediction of paclitaxel sensitivity by CDK1 and CDK2 activity in human breast cancer cells - Breast Cancer Research

Paclitaxel incorporated in hydrophobically derivatized hyperbranched polyglycerols for intravesical bladder cancer therapy.

The activity of carboplatin and paclitaxel for recurrent cervical cancer after definitive radiotherapy. - Gynecological Oncology

Combination of gemcitabine and paclitaxel as second-line chemotherapy for advanced urothelial carcinoma.

Epistaxis during treatment with paclitaxel.

HER2 and Response to Paclitaxel in Node-Positive Breast Cancer - New England Journal of Medicine